Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 78

1.

Is there an association between drugs and burning mouth syndrome? A case-control study.

Azzi L, Veronesi G, Tagliabue A, Croveri F, Maurino V, Reguzzoni M, Tettamanti L, Protasoni M, Spadari F.

Oral Dis. 2019 Sep;25(6):1634-1644. doi: 10.1111/odi.13116. Epub 2019 May 28.

PMID:
31066953
2.

Correlation Between Maxillary Canine Impaction and Facial Biotype.

Crincoli V, Tettamanti L, Lucchina AG, Dedola A, Cazzolla AP, Lacaita MG, Mastrangelo F.

J Craniofac Surg. 2019 Jun;30(4):1044-1048. doi: 10.1097/SCS.0000000000005279.

PMID:
30839460
3.

Stimulated mast cells release inflammatory cytokines: potential suppression and therapeutical aspects.

Varvara G, Tettamanti L, Gallenga CE, Caraffa Al, D'Ovidio C, Mastrangelo F, Ronconi G, Kritas SK, Conti P.

J Biol Regul Homeost Agents. 2018 Nov-Dec;32(6):1355-1360.

PMID:
30574739
4.

Chronic ulcerative stomatitis: A comprehensive review and proposal for diagnostic criteria.

Azzi L, Cerati M, Lombardo M, Pellilli M, Croveri F, Maurino V, Tagliabue A, Tettamanti L, Olszewska M.

Oral Dis. 2019 Sep;25(6):1465-1491. doi: 10.1111/odi.13001. Epub 2019 Jan 6.

PMID:
30457193
5.

IL-33 mediates allergy through mast cell activation: Potential inhibitory effect of certain cytokines.

Tettamanti L, Kritas SK, Gallenga CE, D'Ovidio C, Mastrangelo F, Ronconi G, Caraffa Al, Toniato E, Conti P.

J Biol Regul Homeost Agents. 2018 Sep-Oct;32(5):1061-1065.

PMID:
30334399
6.

Immediate Postextractive Implants With and Without Bone Graft: 3-year Follow-up Results From a Multicenter Controlled Randomized Trial.

Mastrangelo F, Gastaldi G, Vinci R, Troiano G, Tettamanti L, Gherlone E, Lo Muzio L.

Implant Dent. 2018 Dec;27(6):638-645. doi: 10.1097/ID.0000000000000816.

PMID:
30260821
7.

Critical role of inflammatory mast cell in fibrosis: Potential therapeutic effect of IL-37.

Conti P, Caraffa A, Mastrangelo F, Tettamanti L, Ronconi G, Frydas I, Kritas SK, Theoharides TC.

Cell Prolif. 2018 Oct;51(5):e12475. doi: 10.1111/cpr.12475. Epub 2018 Jul 30. Review.

PMID:
30062695
8.

Mast cells participate in allograft rejection: can IL-37 play an inhibitory role?

Conti P, Caraffa A, Ronconi G, Kritas SK, Mastrangelo F, Tettamanti L, Frydas I, Theoharides TC.

Inflamm Res. 2018 Sep;67(9):747-755. doi: 10.1007/s00011-018-1166-3. Epub 2018 Jun 30. Review.

PMID:
29961151
9.

New concepts in neuroinflammation: mast cells pro-inflammatory and anti-inflammatory cytokine mediators.

Caraffa Al, Conti C, D Ovidio C, Gallenga CE, Tettamanti L, Mastrangelo F, Ronconi G, Kritas SK, Conti P.

J Biol Regul Homeost Agents. 2018 May-Jun;32(3):449-454.

PMID:
29921369
10.

Impact of mast cells in depression disorder: inhibitory effect of IL-37 (new frontiers).

Conti P, Caraffa A, Ronconi G, Conti CM, Kritas SK, Mastrangelo F, Tettamanti L, Theoharides TC.

Immunol Res. 2018 Jun;66(3):323-331. doi: 10.1007/s12026-018-9004-9. Review.

PMID:
29907890
11.

A new implant-abutment connection for bacterial microleakage prevention: an in vitro study.

Tettamanti L, Cura F, Andrisani C, Bassi MA, Silvestrerangil J, Tagliabue A.

Oral Implantol (Rome). 2017 Sep 27;10(2):172-180. doi: 10.11138/orl/2017.10.2.172. eCollection 2017 Apr-Jun.

12.

Immediate loading implants: review of the critical aspects.

Tettamanti L, Andrisani C, Bassi MA, Vinci R, Silvestre-Rangil J, Tagliabue A.

Oral Implantol (Rome). 2017 Sep 27;10(2):129-139. doi: 10.11138/orl/2017.10.2.129. eCollection 2017 Apr-Jun. Review.

13.

Post extractive implant: evaluation of the critical aspects.

Tettamanti L, Andrisani C, Bassi MA, Vinci R, Silvestre-Rangil J, Tagliabue A.

Oral Implantol (Rome). 2017 Sep 27;10(2):119-128. doi: 10.11138/orl/2017.10.2.119. eCollection 2017 Apr-Jun. Review.

14.

Pregnancy and periodontal disease: does exist a two-way relationship?

Tettamanti L, Lauritano D, Nardone M, Gargari M, Silvestre-Rangil J, Gavoglio P, Tagliabue A.

Oral Implantol (Rome). 2017 Sep 27;10(2):112-118. doi: 10.11138/orl/2017.10.2.112. eCollection 2017 Apr-Jun. Review.

15.

Impact of Fungi on Immune Responses.

Conti P, Tettamanti L, Mastrangelo F, Ronconi G, Frydas I, Kritas SK, Caraffa A, Pandolfi F.

Clin Ther. 2018 Jun;40(6):885-888. doi: 10.1016/j.clinthera.2018.04.010. Epub 2018 May 8.

PMID:
29752039
16.

Low-grade chronic inflammation mediated by mast cells in fibromyalgia: role of IL-37.

Mastrangelo F, Frydas I, Ronconi G, Kritas SK, Tettamanti L, Caraffa Al, D Ovidio C, Younes A, Gallenga CE, Conti P.

J Biol Regul Homeost Agents. 2018 Mar-Apr;32(2):195-198.

PMID:
29684996
17.

Different signals induce mast cell inflammatory activity: inhibitory effect of Vitamin E.

Tettamanti L, Caraffa Al, Mastrangelo F, Ronconi G, Kritas S, Frydas I, Conti P.

J Biol Regul Homeost Agents. 2018 Jan-Feb;32(1):13-19.

PMID:
29504360
18.

The role of zinc plus octenidine in the regulation of gene expression: an in vitro study.

Lauritano D, Candotto V, Bignozzi CA, Pazzi D, Carinci F, Cura F, Tagliabue A, Tettamanti L.

J Biol Regul Homeost Agents. 2018 Jan-Feb;32(2 Suppl. 1):237-244.

PMID:
29460548
19.

Zinc plus octenidine: a new formulation for treating periodontal pathogens. A single blind study.

Lauritano D, Candotto V, Bignozzi CA, Pazzi D, Carinci F, Cura F, Tagliabue A, Tettamanti L.

J Biol Regul Homeost Agents. 2018 Jan-Feb;32(2 Suppl. 1):231-236.

PMID:
29460547
20.

FDPS finish line design and tooth preparation technique.

Ottria L, Tettamanti L, Guzzo F, Gargari M, Barlattani A.

J Biol Regul Homeost Agents. 2018 Jan-Feb;32(2 Suppl. 1):223-229.

PMID:
29460546

Supplemental Content

Loading ...
Support Center